Glen Santangelo
Stock Analyst at Jefferies
(2.49)
# 2,415
Out of 5,008 analysts
79
Total ratings
47.06%
Success rate
2.42%
Average return
Main Sectors:
Stocks Rated by Glen Santangelo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Maintains: Buy | $130 → $134 | $88.50 | +51.41% | 6 | Sep 3, 2025 | |
| TDOC Teladoc Health | Maintains: Hold | $10 → $8 | $8.37 | -4.42% | 7 | Apr 21, 2025 | |
| ANIP ANI Pharmaceuticals | Initiates: Buy | $80 | $91.68 | -12.74% | 1 | Mar 14, 2025 | |
| VTRS Viatris | Maintains: Buy | $15 → $13 | $10.14 | +28.21% | 4 | Mar 7, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $51 | $37.91 | +34.53% | 1 | Feb 11, 2025 | |
| XERS Xeris Biopharma Holdings | Reiterates: Buy | $4 → $6 | $8.28 | -27.54% | 2 | Jan 29, 2025 | |
| NVST Envista Holdings | Maintains: Hold | $20 → $22 | $20.42 | +7.74% | 1 | Jan 23, 2025 | |
| XRAY DENTSPLY SIRONA | Downgrades: Hold | $30 → $20 | $12.33 | +62.21% | 2 | Jan 23, 2025 | |
| PCRX Pacira BioSciences | Maintains: Buy | $15 → $18 | $23.62 | -23.79% | 5 | Sep 24, 2024 | |
| PGNY Progyny | Maintains: Buy | $31 → $24 | $20.00 | +20.00% | 4 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $23 | $57.97 | -60.32% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $23 | $20.07 | +14.60% | 4 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $41 → $44 | $33.39 | +31.78% | 3 | Jun 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $20.45 | -16.87% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $230 | $142.77 | +61.10% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $4.61 | +2,069.20% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $70 | $25.83 | +171.00% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $55 | $40.99 | +34.18% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $10.84 | +47.60% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $14 | $5.67 | +146.91% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $46 | $71.38 | -35.56% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $31 → $28 | $2.85 | +882.46% | 2 | Mar 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $23.41 | +199.02% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $120 | $6.04 | +1,886.75% | 3 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $2 | $2.73 | -26.74% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $4.39 | +970.62% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $3.19 | +1,028.53% | 1 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $77.12 | - | 3 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $173 → $169 | $750.13 | -77.47% | 5 | May 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $156.65 | - | 4 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $79 → $82 | $64.88 | +26.39% | 2 | Apr 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $130.47 | +91.61% | 1 | Dec 8, 2017 |
HealthEquity
Sep 3, 2025
Maintains: Buy
Price Target: $130 → $134
Current: $88.50
Upside: +51.41%
Teladoc Health
Apr 21, 2025
Maintains: Hold
Price Target: $10 → $8
Current: $8.37
Upside: -4.42%
ANI Pharmaceuticals
Mar 14, 2025
Initiates: Buy
Price Target: $80
Current: $91.68
Upside: -12.74%
Viatris
Mar 7, 2025
Maintains: Buy
Price Target: $15 → $13
Current: $10.14
Upside: +28.21%
Waystar Holding
Feb 11, 2025
Initiates: Buy
Price Target: $51
Current: $37.91
Upside: +34.53%
Xeris Biopharma Holdings
Jan 29, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $8.28
Upside: -27.54%
Envista Holdings
Jan 23, 2025
Maintains: Hold
Price Target: $20 → $22
Current: $20.42
Upside: +7.74%
DENTSPLY SIRONA
Jan 23, 2025
Downgrades: Hold
Price Target: $30 → $20
Current: $12.33
Upside: +62.21%
Pacira BioSciences
Sep 24, 2024
Maintains: Buy
Price Target: $15 → $18
Current: $23.62
Upside: -23.79%
Progyny
Sep 19, 2024
Maintains: Buy
Price Target: $31 → $24
Current: $20.00
Upside: +20.00%
Jun 27, 2024
Maintains: Hold
Price Target: $14 → $23
Current: $57.97
Upside: -60.32%
Jun 27, 2024
Maintains: Buy
Price Target: $19 → $23
Current: $20.07
Upside: +14.60%
Jun 7, 2024
Upgrades: Buy
Price Target: $41 → $44
Current: $33.39
Upside: +31.78%
Dec 19, 2023
Initiates: Buy
Price Target: $17
Current: $20.45
Upside: -16.87%
Dec 19, 2023
Assumes: Buy
Price Target: $230
Current: $142.77
Upside: +61.10%
Dec 15, 2023
Reiterates: Buy
Price Target: $100
Current: $4.61
Upside: +2,069.20%
Jul 25, 2023
Reinstates: Buy
Price Target: $70
Current: $25.83
Upside: +171.00%
Oct 21, 2022
Initiates: Hold
Price Target: $55
Current: $40.99
Upside: +34.18%
Oct 21, 2022
Initiates: Buy
Price Target: $16
Current: $10.84
Upside: +47.60%
Oct 21, 2022
Assumes: Buy
Price Target: $14
Current: $5.67
Upside: +146.91%
May 18, 2022
Maintains: Buy
Price Target: $78 → $46
Current: $71.38
Upside: -35.56%
Mar 17, 2022
Upgrades: Buy
Price Target: $31 → $28
Current: $2.85
Upside: +882.46%
Dec 2, 2021
Initiates: Buy
Price Target: $70
Current: $23.41
Upside: +199.02%
Dec 2, 2021
Initiates: Hold
Price Target: $120
Current: $6.04
Upside: +1,886.75%
Dec 2, 2021
Initiates: Hold
Price Target: $2
Current: $2.73
Upside: -26.74%
Dec 2, 2021
Initiates: Buy
Price Target: $47
Current: $4.39
Upside: +970.62%
Dec 2, 2021
Initiates: Buy
Price Target: $36
Current: $3.19
Upside: +1,028.53%
Mar 17, 2021
Downgrades: Neutral
Price Target: n/a
Current: $77.12
Upside: -
May 21, 2020
Maintains: Hold
Price Target: $173 → $169
Current: $750.13
Upside: -77.47%
Dec 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $156.65
Upside: -
Apr 24, 2018
Maintains: Buy
Price Target: $79 → $82
Current: $64.88
Upside: +26.39%
Dec 8, 2017
Initiates: Hold
Price Target: $250
Current: $130.47
Upside: +91.61%